3rd Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 348 (113th), H.R. 672 (113th), S. 1365 (113th)

Insurance INS

HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness ActSpecialty drug costs

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 672 (113th), S. 1365 (113th), S. 348 (113th)

Pharmacy PHA

HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1365 (113th), S. 348 (113th), H.R. 672 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.